Nagoya University · Medicine
Tomoki Ebata 교수의 연구실은 간담도암을 중심으로 한 간담도계 암의 수술적 치료 및 예후 개선 전략을 연구하고 있습니다. 특히, 복합적이고 난이도 높은 간장기절제술(HPD)의 기술적 안정성과 장기적 생존율 향상을 위한 수술 기준 및 절제 범위 설정에 중점을 두고 있으며, 전신 면역 반응 조절과 장내 미생물 환경 개선을 위한 사전 항생제 및 프로바이오틱스 사용의 임상적 유용성에 대해서도 연구하고 있습니다. 이는 간담도암 환자의 합병증 감소와 생존율 향상에 기여할 잠재력을 지닌 종합적 접근입니다.
Figures are computed from collected data and may differ slightly.
Preoperative oral administration of synbiotics can enhance immune responses, attenuate systemic postoperative inflammatory responses, and improve intestinal microbial environment. These beneficial effects likely reduce postoperative infectious complications after hepatobiliary resection for biliary tract cancer.
HPD is technically demanding and is associated with high morbidity. However, this surgery can be performed with low mortality and offers a better probability of long-term survival in selected patients. As hepatobiliary surgeons, we should consider HPD to be a standard procedure for laterally advanced cholangiocarcinomas that are otherwise unresectable.
For eradication of invasive extrahepatic bile duct carcinoma, a 10-mm margin is required. However, additional removal of any non-invasive component requires a 20-mm margin. These guidelines should be followed in any operation performed with curative intent.
PVE can be performed safely in patients with cholestatic liver, and it has a potential benefit for patients with advanced biliary cancer who are to undergo extended, difficult hepatectomy.
Combining EHC and IHC under the term perihilar cholangiocarcinoma is valid, as these tumours have comparable biological behaviour, with similar clinical management depending on stage and invasion.
The present review article will update the knowledge on biliary tract cancers, en hancing the quality of daily clinical practice. However, many features about these cancers remain unknown; further studies are required to establish disease-specific optimal treatment strategies.
Open papers in the app to read, cite, and organize with AI.